Skip to Main Content
Text size: SmallMediumLargeExtra-Large

Myung Hee Park, Ph.D.

Myung Hee Park, Ph.D.Senior Investigator
Chief, Molecular and Cellular Biochemistry Section

BETHESDA MD 20892-4340

Phone: (301) 496-5056
Fax: (301) 402-0823

Biographical Sketch

Myung Hee Park has been chief of the Molecular and Cellular Biochemistry Section, Oral and Pharyngeal Cancer Branch since 1998. She leads a research group exploring the role of polyamines and a polyamine-modified cellular protein, eukaryotic translation initiation factor 5A (eIF5A) in eukaryotic protein synthesis, cell proliferation and tumorigenesis.  She has discovered a new cellular pathway in which one cellular protein, the eIF5A precursor, is modified by the polyamine spermidine to convert its specific lysine residue to a unique amino acid, hypusine, and demonstrated that hypusine modification is required for the activity of eIF5A in protein synthesis and cell proliferation. Her group further established the enzymatic steps of hypusine synthesis and cloned, purified and characterized the mechanism and structural properties of the two enzymes, deoxyhypusine synthase and deoxyhypusine hydroxylase. They developed potent inhibitors of the enzymes for their potential application in the treatment of various diseases, including cancer, diabetes and HIV1 infection, in which eIF5A has been implicated.

Dr. Park received her Ph.D. in chemistry from Brown University in 1976.  She did her postdoctoral work at the Massachusetts Institute of Technology (1976-1978).  In 1979, she joined NIDCR and initiated her research on hypusine, eIF5A and polyamines. 

She is recognized for her pioneering research on the hypusine modification of eIF5A and studies on the functions of polyamines and eIF5A as key regulators in eukaryotic cells. She has published her original studies in prestigious journals and has been invited to speak at many national and international meetings.

Research Interests/Scientific Focus

We have been interested in four related topics:

  1. the role of polyamines in cellular regulation
  2. characterization of the hypusine modification pathway in eIF5A
  3. the mechanism of eIF5A action in protein synthesis
  4. the role of eIF5A isoforms in cell proliferation, animal development and tumorigenesis
  • The polyamines (putrescine, spermidine and spermine) are ubiquitous polycations in living organisms and are absolutely required for growth and development in the eukaryotic kingdom. They have been implicated in diverse biological regulation at the levels of transcription, translation, posttranslational processing and modification, ion channel gating, and membrane stability. Polyamine levels within cells control cell proliferation, differentiation , apoptosis and transformation. Although the precise molecular mechanisms of polyamine regulation have been elucidated in a few specific cases, their major function in global cell physiology is still poorly understood. We are studying polyamine function by transfection of the polyamine metabolic enzyme spermidine/spermine acetyltransferase 1 (SSAT1) in mammalian cells. Overexpression of this enzyme results in almost complete depletion of cellular polyamines. When SSAT1 is cotransfected with a reporter gene GFP, GFP expression is totally blocked. We are investigating the mechanism underlying the inhibition of the expression of the reporter gene in polyamine-depleted cells.
  • One specific function of a cellular polyamine is defined by the requirement for spermidine for the activation of eukaryotic translation initiation factor 5A (eIF5A)  through its posttranslational modification. We discovered this pathway and established the mechanism of hypusine synthesis in eIF5A and the essential role of the hypusine/deoxyhypusine modification in the activity of eIF5A and in eukaryotic cell proliferation. The biosynthesis of hypusine occurs in two enzymatic steps. In the first step, deoxyhypusine synthase catalyzes the transfer of the 4-aminobutyl moiety of spermidine to a specific lysine residue of the eIF5A precursor to form a deoxyhypusine residue. This intermediate is hydroxylated by deoxyhypusine hydroxylase to complete hypusine synthesis and eIF5A activation. Potent inhibitors of the first step enzyme, deoxyhypusine synthase, have been developed and shown to exert strong antiproliferative effects in mammalian cells including human cancer cells. We are investigating the structure and mechanism of deoxyhypusine hydroxylase to develop specific inhibitors as potential therapeutic agents against cancer and HIV1 infection.
  • Although eIF5A stimulates the first peptide bond formation in an in vitro methionyl-puromycin synthesis assay, its precise mode of action and its physiological function are not fully understood. Recent polysome analyses data in yeast and mammalian cells suggest a role for eIF5A in the elongation step of translation. eIF5A binding to ribosome was reported to be  dependent on the hypusine modification. The characterization of eIF5A binding to the ribosome will provide new insights into the mode of its action. We constructed a polycistronic vector to co-overexpress eIF5A, deoxyhypusine synthase and deoxyhypusine hydroxylase in E. coli and purified large quantities of highly pure recombinant eIF5A proteins containing either hypusine, deoxyhypusine or lysine to carry out structure/function studies and ribosome binding studies.
  • eIF5A exists in two closely related  isoforms in mammals. Both isoforms have been implicated in certain human neoplasia/cancers as a diagnostic or a prognostic marker. Although eIF5A-1 levels are often enhanced in rapidly proliferating tissues such as cancer, it is constitutively expressed in all cells and tissues. On the contrary, eIF5A-2 is expressed in a tissue-specific manner in brain and testis and is not detected in other normal tissues, suggesting a differentiated function for this isoform. eIF5A-2 expression is enhanced in various human cancer tissues and cells and this isoform has been proposed as an oncogene. In order to determine the role of eIF5A in animal development, we have generated heterozygous knockout mice lacking eIF5A-1 or deoxyhypusine synthase gene. The Eif5a-1-/- or Dhps-/- homozygous knockout leads to early embryonic lethality on the stage of  E6.5,  indicating their vital role in early embryonic development. We have also generated transgenic mice expressing human eIF5A-1 or eIF5A-2 to determine whether overexpression of either isoform alters the sensitivity of mice to chemically induced carcinogenesis in animal tumor models.

Selected Publications

  1. Park MH, Cooper HL and Folk JE (1981) Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc. Natl. Acad. Sci. USA 78:2869-2873. PMID: 6789324
  2. Cooper HL, Park MH and Folk JE (1982) Posttranslational formation of hypusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth.  Cell 29:791-797. PMID: 6817926
  3. Park MH (1989) The essential role of hypusine in eukaryotic translation initiation factor 4D (eIF-4D): purification of eIF-4D and its precursors and comparison of their activities. J. Biol. Chem. 264: 18531-18535. PMID: 2509461
  4. Park MH, Wolff EC and Folk JE (1993) Review. Is hypusine essential for eukaryotic cell proliferation? Trends in Biochemical Sciences 18: 475-479. PMID: 8108861
  5. Park MH, Wolff EC, Lee YB and Folk JE (1994) Antiproliferative effects of     inhibitors of deoxyhypusine synthase: inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J. Biol. Chem. 269: 27827-27832. PMID 7961711
  6. Wolff EC, Lee YB, Chung SI, Folk JE and Park MH (1995) Deoxyhypusine    synthase from rat testis: purification and characterization. J. Biol Chem. 270: 8660-8666. PMID: 7721768
  7. Joe YA, Wolff EC and Park MH (1995) Cloning and expression of human     deoxyhypusine synthase cDNA: structure-function studies with the recombinant enzyme and mutant proteins. J. Biol. Chem. 270: 22386-22393. PMID: 7673224
  8. Joe YA, Wolff EC, Lee YB and Park MH (1997) Enzyme-substrate intermediate at a specific lysine residue is required for deoxyhypusine synthesis: the role of Lys329 in human deoxyhypusine synthase  J. Biol. Chem.  272: 32679-326785, PMID: 9405486
  9. Umland TC, Wolff EC, Park MH and Davies DR (2004) A new crystal structure of deoxyhypusine synthase reveals the configuration of the active site enzyme and of an enzyme:NAD:inhibitor ternary complex. J. Biol. Chem. 279, 28697-28705, PMID: 15100216
  10. Park, J-H, Aravind, L, Wolff, EC, Kaevel, J, Kim, YS and Park MH. (2006) Molecular   cloning, expression and structural prediction of deoxyhypusine hydroxylase: a novel HEAT-repeat-containing metalloenzyme, Proc. Natl. Acad. Sci. USA, 103:51-6., PMID: 16371467
  11. Kim YS, Kang KR, Wolff EC, Bell JK, McPhie P and Park MH. (2006) Deoxyhypusine hydroxylase is a Fe(II)-dependent HEAT-repeat enzyme: Identification of amino acid residues critical for Fe(II) binding and catalysis. J. Biol. Chem. 281:13217-25, PMID: 16533814
  12. Chattopadhyay MK, Park MH and Tabor H. (2008) Hypusine modification for growth is the major function of spermidine in Saccharomyces cerevisiae polyamine auxotrophs grown in limiting spermidine. Proc Natl Acad Sci USA 105: 6554-6559, PMID: 18451031
  13. Landau GB, Bercovich Z, Park MH and Kahana C, (2010) The role of polyamines in supporting growth of mammalian cells is mediated through their requirement for translation initiation and elongation J Biol Chem 285:12474-12481, PMID 20181941
  14. Lee SB, Park J-H, Woster PM, Casero RA and Park MH. (2011) Suppression of exogenous gene expression by spermidine/spermine-N1-acetyltransferase (SSAT1) cotransfection, J Biol Chem 2010:285:15548-15556 PMID 20212040
  15. Park J-H, Johansson HE, Aoki H, Huang BX, Kim H-Y, Ganoza MC and Park MH (2012) Post-translational modification by β-lysylation is required for the activity of E. coli Elongation Factor P (EF-P). J Biol Chem in press  PMID: 22128152,  Nov 29 2011 Epub ahead  of print


  • US Patent No 5,344,846, September 6, 1994   Jakus J, Park MH, Wolff EC. and Folk JE (1994) Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
  • US Patent No. 7,141,589, November 28, 2006    Park MH, Clement PMJ, Hanauske-Abel HM, Wolff EC, Kleinman HK and Cracchiolo BM (2003) Method of inhibiting formation of vascular channels and methods of inhibiting proliferation.  International Publication Number WO 03/018014; International Publication Date 06.03.2003  Priority Date August 23 2001; International Patent Application under the Patent Cooperation Treaty (PCT) International Application Number PCT/US02/26909 Filing Date August 23.2002
  • US Provisional Patent Application No  PCT/US03/28742, Sept 13, 2003; 10/527,453 601-1-135PCT   WO 2004/024087 25 March 2004; Hanauske-Abel HM, Popowicz  A, Wolff EC, Clement PMJ, Park MH, Cracchiolo BM. Methods of Diagnosing and Treating Hyperproliferative Disorders  E308-2033 /3-PCT-02
  • US Provisional Patent Application No  PCT W02005/055931A2) December 2003 Hanauske-Abel HM, Palumbo P, Cracchiolo BM, Park MH, Wolff EC, Hanauske A-R and McLendon G.  Method of preventing survival of retrovirally infected cells and of inhibiting formation of infectious retroviruses

Complete CV and Publications (PDF File, 97KB)

Share This Page

GooglePlusExternal link – please review our disclaimer

LinkedInExternal link – please review our disclaimer


This page last updated: May 28, 2014